We recently reported a novel identification of the extracellular release of prominin-1-containing membrane microvesicles from human FEMX-I metastatic melanoma cells, and suggested that prominin-1 microvesicles influence the metastatic capacity of FEMX-I cells [9]. Here, PROM1 is linked to metastatic melanoma.